SBT-100 Pipeline

SBT Pipeline

Development Stage

Therapeutic Indication Research Preclinical Phase 1 Comments
SBT-100 (KRAS, P-STAT3) Breast Cancer (TNBC, ER+/PR+, HER2+)
2024 Tested In Vitro and In Vivo
Prostrate Cancer
Tested In Vitro, In Vivo In Progress
Glioblastoma
Tested In Vitro
Sarcoma
2024 Orphan Drug Status Granted by FDA
Pancreatic Cancer
2024 Orphan Drug Status Granted by FDA